NCT03081468

Brief Summary

In current, clinical ophthalmology, a range of specialised testing allows comprehensive evaluation of ocular health. These tests have typically evolved over many years to ensure their clinical validity. For example, the assessment of visual acuity has traditionally been measured with Snellen letter charts from a distance of six metres (20 feet), leading to the phrase "20/20 vision". Despite this, the limitations of Snellen testing are well established and more sophisticated testing is now available (e.g., logMAR testing using ETDRS (Early Treatment Diabetic Retinopathy Study) charts). Many other diagnostic tests have undergone similar cycles of refinement, often over extended time periods. Therefore, it should be incumbent on any new device to undergo detailed evaluation of its validity (how its measurements agree with other testing) and its repeatability (the variability when a further measurement is obtained in short time period, by the same operator and under the same conditions). Binocular OCT extends the application of OCT devices beyond that of simple, cross- sectional imaging to a diverse array of diagnostic tests. The binocular design also removes the need for additional personnel to perform testing (i.e., the device can be self-operated in an automated manner), and allows for novel testing to be performed that is not possible with monocular imaging. In particular, binocular OCT devices have the potential to perform automated, quantitative pupillary measurements - an entirely novel application for this imaging modality. This study will assess the validity and repeatability of pupil measurements using binocular OCT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 16, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

May 18, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2017

Completed
Last Updated

April 6, 2018

Status Verified

April 1, 2018

Enrollment Period

7 months

First QC Date

March 10, 2017

Last Update Submit

April 5, 2018

Conditions

Keywords

Optical coherence tomographyPupillometryAutomatedBinocular

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy of the binocular OCT

    The primary objective will be to determine the diagnostic accuracy of a prototype binocular OCT system for the detection of relative afferent pupillary defect (RAPD).

    6 months

Secondary Outcomes (1)

  • Test-retest variability of the binocular OCT pupillometry assessment

    6 months

Study Arms (2)

Healthy volunteers

Fifty healthy volunteers. Each participant will attend for a single study visit, lasting approximately 1 hour in duration. Participants will undergo pupillometry examination using the binocular OCT prototype and Konan RAPDx.

Device: Binocular OCT prototypeDevice: Konan RAPDx

Participants with confirmed relative afferent pupillary defect

Fifty participants with with eye disease (retinal disease, glaucoma, and neuro-ophthalmic conditions) and confirmed relative afferent pupillary defect. Each participant will attend for a single study visit, lasting approximately 1 hour in duration. Participants will undergo pupillometry examination using the binocular OCT prototype and Konan RAPDx.

Device: Binocular OCT prototypeDevice: Konan RAPDx

Interventions

Participants in the study will undergo pupil measurement using a prototype binocular OCT imaging system (Envision Diagnostics, Inc., CA). For the binocular OCT imaging system, testing will be performed twice in the same session, by the same examiner, to allow assessment of repeatability (test-retest variability).

Healthy volunteersParticipants with confirmed relative afferent pupillary defect

Participants in the study will undergo pupil measurement using a validated, commercially available pupilometer (RAPDx; Konan Medical USA, Inc., Irvine, CA).

Healthy volunteersParticipants with confirmed relative afferent pupillary defect

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants with eye disease (retinal disease, glaucoma, and neuro-ophthalmic conditions), and confirmed relative afferent pupillary defect as measured with RAPDx, and participants with no ocular abnormality ("healthy volunteers") will be recruited for the study.

You may qualify if:

  • Presence of RAPD as measured with RAPDx
  • Presence of retinal disease, glaucoma or neuro-ophthalmic conditions that affect the optic nerve
  • Male or female, aged 18 years or older
  • Ability to understand nature/purpose of the study and to provide informed consent
  • Ability to undergo binocular OCT imaging
  • Ability to follow instructions and complete the study
  • Ability to speak English

You may not qualify if:

  • Optical media opacity sufficient to preclude adequate ocular imaging with OCT
  • Ptosis (drooping of the upper eyelid) sufficient to preclude visualization of the pupils using OCT
  • Significant pupil irregularity that precludes reliable measurement of RAPD
  • Any condition that is likely to interfere with pupillary constriction (e.g., iris pathology)
  • Hearing impairment sufficient to interfere with hearing instructions
  • Any condition which, in the investigator's opinion, would conflict or otherwise prevent the subject from complying with the required procedures, schedule, or other study conduct.
  • No self-reported ocular history (although wearing corrective prescription glasses is permitted)
  • Male or female, aged 18 years or older
  • Ability to understand nature/purpose of the study and to provide informed consent
  • Ability to undergo binocular OCT imaging
  • Ability to follow instructions and complete the study
  • Ability to speak English
  • Presence of ocular pathology, including ptosis or pupil irregularities
  • Hearing impairment sufficient to interfere with hearing instructions
  • Any condition which, in the investigator's opinion, would conflict or otherwise prevent the subject from complying with the required procedures, schedule, or other study conduct.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moorfields Eye Hospital NHS FT

London, EC1V 2PD, United Kingdom

Location

MeSH Terms

Conditions

Pupil Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2017

First Posted

March 16, 2017

Study Start

May 18, 2017

Primary Completion

November 30, 2017

Study Completion

November 30, 2017

Last Updated

April 6, 2018

Record last verified: 2018-04

Locations